World Articles in Ear Nose and Throat 
Newborn Hearing Screening - Otoacoustic Emisssions
 
ENT USA
Recommended Link

 
Hearing Assessment of Children

Authors:   Parin Patel*, Vikas Sinha**, Viral A. Chhaya***, Dilavar A. Barot****, Niral Modi****, Hiten Maniyar****, Vishal Parmar*****, Prashanth C.D.*****, Jay Dave*****, Nikhil Gupta*****, Kapil*****, Deepanshu Gurnani*****, Toral Patel*****, Nehal Patel*****.

* Assistant Professor, PDU Medical college. ** Dean, Professor E.N.T., M.P.Shah Medical College, *** Professor and Head, M.P.Shah Medical College, **** Assistant Professor, M.P.Shah Medical College, ***** Junior Resident, M.P.Shah Medical College

Institution:   PDU Medical college Rajkot,India & Department of Otolaryngology and Head and Neck Surgery, M.P.Shah Medical College,  Jamnagar (Gujarat), India

Corresponding Author: 

Dr. Vikas Sinha
Dean, Prof E.N.T.
M.P. Shah Medical College
Jamnagar (Gujarat), India

E mail dr_sinhavikas@yahoo.co.in

Abstract:

The primary value of OAEs (otoacoustic emissions) is that their presence indicates that a preneural cochlear receptor mechanism is able to respond to sound normally.  Emissions are frequency specific and frequency selective, so that it is possible to gain information about different parts of the cochlea simultaneously.  This is a study of 100 suspected children (neonatal hyberbilirubinemia, convulsion, neonatal intensive care unit (NICU) admission, ototoxic drug exposure and other predisposing factors) which were referred from a Pediatric Outdoor Patient Department and Neonatal Intensive Care Unit (NICU).  OAEs were performed in all of the above mentioned children.  The data was analyzed and results were compiled.  These results were compared with other studies to identify the most likely risk factor associated with childhood hearing impairment.  OAEs can be used as a neonatal screening tool as well as for the evaluation of a suspected pediatric population to help diagnose childhood hearing impairment at a very early stage, allowing for the rehabilitation the child within the critical period for speech and language development.

 
Introduction:

OAEs (otoacoustic emissions) were first reported by Kemp in 1978.  OAEs testing is the recording of sounds that are produced by the ear itself.  They appear to be generated by motile elements in the cochlear outer hair cells.  The sounds generated by the cochlear outer hair cells are small but potentially audible, and detected by microphones instead of electrodes. There are two types of OAEs:1

1. Spontaneous OAEs are sounds emitted from the non-linear outer hair cells' activity without acoustic stimulation. They are emitted spontaneously.  Spontaneous Otoacoustic emissions are found only in 50% of normal hearing adults and children.

2. Evoked OAEs are in response to acoustic stimulation.  Evoked OAEs are further subdivided into three categories:

a) Transient evoked otoacoustic emissions (TEOAEs):  Sounds emitted in response to an acoustic stimulus of very short duration usually clicks but it can be a tone burst.  TEOAEs are evaluated in terms of amplitude (dB SPL), percentage reproducibility, and amplitude/noise (SNR).  Most commonly, 80-85dB SPL stimuli are used clinically.

b) Distortion product Otoacoustic emissions (DPOAEs):  Sounds emitted in response to two simultaneous tones of different frequencies.  The frequencies of the two sinusoidal signals are designated as f1 and f2 (f2>f1) and corresponding intensity levels are L1 and L2.  When f1 and f2 are close in frequency, interaction of the two sinusoidal signals result in inter-modulation distortion that undergo reverse transduction through the middle ear and are converted to an acoustic that can be measured in the ear canal.  The level of stimuli is approximately 75dB SPL with a  frequency ratio (f2/f1) = 1.21.2.  DPOAEs allow greater frequency specificity.  Any external, middle and inner ear pathology can lead to absence of Otoacoustic emissions.

C) Sustained-frequency Otoacoustic emission (SPOAEs):  Sounds emitted in response to a continuous tone.  This is the most frequency-specific OAEs.

OAE MachineMechanism for the generation of otoacoustic emission:3  The basilar membrane receives sound energy delivered to the cochlear fluid from the middle ear. Sounds entering the cochlea result in a ripple wave along the basilar membrane which travels from the base to the apex.  Low frequencies are focused at the apex while high frequencies are focused at the base.  Sound image quality depends upon the health of the three rows of outer hair cells.  Outer hair cells are responsible for amplification of the travelling waves, resulting in higher and sharper peaks of excitation to the inner hair cells.

An OAE machine is shown on the right.  

Most of the sound vibration generated by the outer hair cells becomes part of the forward travelling waves, but a fraction escapes. It then travels back out of the cochlea to cause secondary vibrations of the middle ear and eardrum. The whole process can take 3 to 15 milliseconds.  These cochlear-driven vibrations are the source of Otoacoustic emissions.  Most cochlear pathologies involve the outer hair cells , making OAEs an ideal frequency-specific screening test for cochlear functions. 

Below are examples of OAE Reports:

OAE Report            OAE Report

The pathologic conditions3 that can cause absence of OAEs are:

Importance of Otoacoustic emissions:3  OAEs (otoacoustic emissions) indicate that the pre-neural cochlear receptor mechanism (and the middle ear mechanism as well) is able to respond to sound in a normal way.  Emissions are frequency specific and frequency selective, so that it is possible to gain information about different parts of the cochlea, simultaneously.  No other clinical test specifically tests the cochlear biomechanics or combines the operational speed, non-invasivity, objectivity, sensitivity, frequency selectivity, and noise immunity as otoacoustic emission testing.  The otoacoustic data does not translate into threshold data.  It does not replace audiometric data and is quite unique to cochlear biomechanics.  The typical 100dB hearing loss gives no response in the same manner as a typical 35dB hearing loss in otoacoustic emission testing.

Permanent childhood hearing impairment (PCHI):4    Hearing impairment is considered to be present when it exceeds 40dB.   The causes of childhood hearing loss may be congenital or acquired.  Congenital hearing loss may be genetic (autosomal dominant, recessive, x-linked or mitochondrial) or non-genetic (infectious, radiation or drug induced).  The acquired hearing loss may be due to hypoxia, hyperbilirubinemia, low-birth weight, meningitis, convulsions, ototoxic drugs trauma, and idiopathic.

The early diagnosis of childhood hearing loss and early intervention is very important for speech and language development of children.  Otoacoustic emission testing is an objective test that can be done at any age and it permits early detection of inner ear abnormalities associated with a wide variety of diseases and disorders, including non-pathologic etiologies like metabolic dysfunction.  It is a screening test and not a confirmatory test.  It does not provide the hearing threshold, but rapidly screens the child.  OAE testing helps to decide whether the child will require further assessment by BERA.
 

Methods:

This is the prospective study of 100 patients that was carried out at the Department of Otolaryngology and Head and Neck Surgery at M.P. Shah Medical College, Jamnagar, India.  A total of 100 children (0 to 5 years) were included in this study.  They were referred from the Pediatric Outdoor Patient Department or admitted in the newborn baby ward and other pediatric wards.  These children were suspected by pediatricians on the basis of their antenatal, intra-natal and postnatal history and suspected to have some hearing impairment and were sent to the ENT Department for further hearing assessment, especially for OAEs testing.  Only those children having intact tympanic membranes were included in this study.  Parents of suspected children which were included in this study were explained the purpose and use of the OAEs.  A detailed procedure was explained after their consent was obtained.  A detailed history including perinatal history was elicited from the parents preferably from the mother.  This was followed by a complete ENT examination5 including otoscopic examination of the ears.  If any wax, debris, or foreign bodies were found in the ear canal, they were removed.  Tympanometry was done in every case to rule out middle ear abnormality.

All OAEs were analyzed relative to the environmental noise-floor level.  Ambient noise was compensated for during OAE testing, therefore, reducing the physiological and acoustic ambient noise which is very critical for good recordings.   For quiet and co-operative patients, recordings usually required less than 5 minutes.  If the results were “Pass” 6 then no follow up OAE was required.  If results were “Refer” then children were called after one month for repeat OAEs testing.  If results still remained “REFER” 6 then candidates were referred for BERA study.  The “Pass” test results means OAEs are present, and one can assume the individual's hearing is at least 30 dB or better.  If there is damage to the outer hair cells producing a mild hearing loss, then OAEs may not present.  If the test result is "Refer”, the child may be at risk for possible communication handicaps and can benefit from further diagnostic assessment and possible rehabilitation.

Exclusion criteria were:
1. Newborns and children with purulent ear discharge, external and middle ear abnormalities.
2. Refusal by parents or guardian for OAE.
3. Tympanic membrane perforation.

Testing procedure:  It is best carried out in a lying down position and when the child is quiet.  Sometimes sedation with syrup pedirest (trichloflous) in a dose of 20 mg/kg (250-500 mg) or (2.5-5ml)7 was given to the child to make them quiet and calm.  Position of a probe was kept stable by securing a probe’s cable to the patient’s clothing throughout the recording to ensure proper testing.  Click stimuli was used at an 85 dB sound pressure level (SPL).  The “Start” frequency (lowest test frequency) is 500 Hz and the “End” frequency (highest test frequency) is 8000 Hz, which is the default procedure that the OAE machine executes.  The passing criteria was determined on the basis of:

a) Dp (distortion product) minus Ns (noise floor) is equal to SNR (signal-to-noise ratio) which is the dB sound pressure level (SPL) and is the absolute signal-to-noise difference.  This allows the user to set the passing criteria to a specific signal-to-noise ratio (SNR).  The specified SNR is the difference between Dp (distortion product) and noise-level mean.  Results are considered “pass” at a specific frequency when a difference is greater than the specified level.

b) Dp (distortion product) minus Ns(noise floor) (in units of standard deviation) is equal to relative signal-to-noise difference.  This option allows the user to set the passing criteria to a specific number of standard deviations above the mean of the noise floor (Ns).  Results are considered “pass” at a given frequency when the difference between the distortion product amplitude and the noise level is greater than the user-specified number.  Patients are considered to have passed a test when the percentage of frequency across the entire testing range is greater than or equal to the percentage entered.  For example, if 80% is entered and the patient passed 9 out of 10 frequencies tested, then the patient is considered to have passed the test.  


Results & Discussion:

In this present study:

Figure 1:  OAE1. 74 (74%) of the cases had “refer” results and 26 (26%) of the cases had “pass” results out of 100 cases. (Figure 1 -- To the right.)

Figure 1:  Pass/Fail rates in test subjects.

Click on Figures and Tables to Enlarge

 

 

2. The maximum patients were in the age group of 0-6 months (40%).   Out of 100 cases, 53 were females and 47 were males.  Female:male ratio=1.12. (Figure 2, Table 1)     Click on Figures and Tables to Enlarge

Table 1.  Age distribution of subjects
Figure 2. Age distribution of subjects Table 1. Age distribution of subjects

3. There were 22 preterm deliveries (including low-birth weight, neonatal intensive care unit (N.I.C.U) admission,8,9 birth asphyxia) out of which 15 children (68%) had a “refer” result. (Figure 3, Table 2a and 2b)   Click on Figures and Tables to Enlarge

Figure 3. Preterm vs Term Births Figure 3. Preterm vs Term Births Table 2B.  High Risk for Health Loss
Figure 3. Preterm vs. Term Delivery Table 2a. Preterm vs. Term Delivery Table 2b.  High Risk for Hearing Loss

4. Seven children (7%) with jaundice (icterus neonatorum),8 seven (7%) children with meningitis and five (5%) children were those children who were exposed to ototoxic drugs during early life.  Ten (10%) children had febrile convulsions during early life and all had  “refer” results.  In the study of Pelagia-Stavroulakil,10 there were 24 children on aminoglycoside therapy out of which 11 were for seven days and 13 were for greater then eight days and were found to have referred OAEs. (Figure 4, Table 3)  Click on Figures and Tables to Enlarge

Figure 4.  High Risk Diagnosis Table 3.  High Risk Diagnosis
Figure 4. High-Risk Diagnosis Table 3. High-Risk Diagnosis

5. Two children with congenital rubella syndrome and five children with cerebral palsy had “refer” results.  Morales Angulo11 in their retrospective study of 64 confirmed cases of cerebral palsy, audiological testing for hearing impairment was done in 30 (47%) patients and out of them 18 (60%) patients had sensorineural hearing loss. (Figure 5, Table 4)  Click on Figures and Tables to Enlarge

Figure 5. High Risk Diagnosis Table 4. High Risk Diagnosis
Figure 5. High-Risk Diagnosis Table 4. High-Risk Diagnosis

6. Five children (5%) who had “refer” results in the present study were the post-lingual hearing loss cases.  Out of these five children, two children had bilateral severe pneumonia and were treated with Amikacin for 21 days and Gentamicin8,10 for 14 days, respectively.  One child had a head injury at the age of three years, one child had meningitis at the age of three years and one child had measles at the age of two and half years.
 

Conclusion:

In this present study, “Hearing assessment in children", 100 children (0-5 yrs) were referred from the Pediatric Department over a two-year period for testing with OAEs (otoacoustic emissions).  Seventy-four cases (74%) had “refer” results and 26 cases (26%) had “pass” results.  All the “refer” cases were advised for BERA (brainstem evoked response audiometry) testing.  Of the 74 cases, only eight cases had undergone BERA examination and all were found to have a profound degree of sensorineural hearing impairment.  The main aim of the study was to demonstrate the utility of OAES to be used as a rapid screening test for hearing impairment in suspected cases of jaundice, convulsions, fever, meningitis, ototoxic drugs, low-birth weight/neonatal intensive care unit (NICU) admission, etc.  The OAE examination is a very rapid, highly sensitive, specific and objective test for the inner ear, especially the outer hair cells of the cochlea and form the basis of screening of newborns for early identification of childhood hearing impairment.   Once a suspected impairment has been identified on screening further testing is done to confirm the suspected diagnosis so early intervention can be carried out for speech and language development of children.  

 
References:

1. Probst R, Lonsbury-Martin BL, Martin GK. A review of otoacoustic emissions. J Acoust Soc Am. 1991 May;89(5):2027-67.  View Abstract

2. Gaskill SA, Brown AM. The behavior of the acoustic distortion product, 2f1-f2, from the human ear and its relation to auditory sensitivity. J Acoust Soc Am. 1990 Aug;88(2):821-39.   View Abstract

3. Kemp DT.  Otoacoutic emissions, their origin in cochlear function and use. British Medical Bulletin.  2002 Oct;63(1),223-241.     View Article

4. Scott Brown, Otolaryngology , Head and Neck surgery, 7th ed. Vol 1, 844-845

5. Sinha Vikas.  Practical E.N.T. 2nd edition; Examination of Ear, 5-33.

6. Hall JW, Adlin D, May K, Bantwal A.  Pediatricians Guide to Otoacoustic Emissions (OAEs) and Tympanometry.    MAICO.  View Article 

7. Triclofos drug information - Drugs Update India    View Article 

8.  Rughani S, Vyas B, Sinha V, et al: Hearing screening in newborns (a cross sectional study), WAENT.com vol (4)1,2011.   View Article

9.  Chiong CM, Dv Llanes EG, Tirona-Remulla AN, Calaquian CM, Reyes-Quintos MR. Neonatal hearing screening in a neonatal intensive care unit using distortion-product otoacoustic emissions. Acta Otolaryngol. 2003 Jan;123(2):215-8.  View Abstract 

10.  Stavroulaki P, Apostolopoulos N, Dinopoulou D, Vossinakis I, Tsakanikos M, Douniadakis D. Otoacoustic emissions--an approach for monitoring aminoglycoside induced ototoxicity in children. Int J Pediatr Otorhinolaryngol. 1999 Nov 5;50(3):177-84.   View Abstract

11.  Morales Angulo C, Azuara Blanco N, Gallo Terán J, González Aledo A, Rama Quintela J. [Sensorineural hearing loss in cerebral palsy patients]. [Article in Spanish] Acta Otorrinolaringol Esp. 2006 Aug-Sep;57(7):300-2.  View Abstract
   

Disclaimer:  Articles appearing in the World Articles in Ear, Nose and Throat (WAENT) may contain statements, opinions, and information that have errors in opinions, facts, figures, conclusions or interpretation.  Thus, Cumberland Otolaryngology Consultants, the publishers, the authors, editors and their respective employees are not responsible or liable for the use of any such information contained in the manuscripts, pictures, movies or other content provided or published by the WAENT.   If inaccuracies are identified, please submit a letter to the editor and contact the WAENT at http://www.entusa.com/contact_us.htm.    Always consult a qualified healthcare provider for advice regarding a medical condition or treatment recommendations. 

Advertisements
 

World Articles in Ear, Nose and Throat  www.waent.org                 Apr. 10, 2012              Vol 5-1

Copyright WAENT 2012 All Rights Reserved
 

Advertisements

Advertisements

Google Ad space finances and sponsors ENT USAsm Websites.  ENT USAsm, Cumberland Otolaryngology or Dr Kevin Kavanagh, MD do not endorse, recommend, refer to or are responsible for the Advertisements or for the content or claims made in the Advertisements.

Learn more about this topic on
ENT USA (dot) Com
View information
 

View Other Articles
On Childhood Hearing Loss. and OAEs